BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35818075)

  • 1. Review and statistical analysis of clinical management of feline leishmaniosis caused by Leishmania infantum.
    Garcia-Torres M; López MC; Tasker S; Lappin MR; Blasi-Brugué C; Roura X
    Parasit Vectors; 2022 Jul; 15(1):253. PubMed ID: 35818075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline leishmaniosis: Is the cat a small dog?
    Pennisi MG; Persichetti MF
    Vet Parasitol; 2018 Feb; 251():131-137. PubMed ID: 29426470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LeishVet update and recommendations on feline leishmaniosis.
    Pennisi MG; Cardoso L; Baneth G; Bourdeau P; Koutinas A; Miró G; Oliva G; Solano-Gallego L
    Parasit Vectors; 2015 Jun; 8():302. PubMed ID: 26041555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and long-term follow-up of a cat with leishmaniosis.
    Brianti E; Celi N; Napoli E; Abbate JM; Arfuso F; Gaglio G; Iatta R; Giannetto S; Gramiccia M; Otranto D
    Parasit Vectors; 2019 Mar; 12(1):121. PubMed ID: 30909954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmaniosis of companion animals in Europe: an update.
    Pennisi MG
    Vet Parasitol; 2015 Feb; 208(1-2):35-47. PubMed ID: 25573248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between feline immunodeficiency virus and Leishmania infantum infections in cats: a retrospective matched case-control study.
    Priolo V; Masucci M; Donato G; Solano-Gallego L; Martínez-Orellana P; Persichetti MF; Raya-Bermúdez A; Vitale F; Pennisi MG
    Parasit Vectors; 2022 May; 15(1):107. PubMed ID: 35534884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmaniasis.
    Baneth G; Solano-Gallego L
    Vet Clin North Am Small Anim Pract; 2022 Nov; 52(6):1359-1375. PubMed ID: 36336425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline leishmaniosis with focus on ocular manifestation: a case report.
    Schäfer I; Schmidt A; Gräßer F; Schieszler A; Aupperle-Lellbach H; Loesenbeck G; Gentil M; Müller E; Naucke TJ
    Parasit Vectors; 2023 May; 16(1):161. PubMed ID: 37173777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania tropica and Leishmania infantum infection in dogs and cats in central Israel.
    Baneth G; Nachum-Biala Y; Adamsky O; Gunther I
    Parasit Vectors; 2022 May; 15(1):147. PubMed ID: 35534906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline leishmaniosis: diagnosis, treatment and outcome in 16 cats.
    Fernandez-Gallego A; Feo Bernabe L; Dalmau A; Esteban-Saltiveri D; Font A; Leiva M; Ortuñez-Navarro A; Peña MT; Tabar MD; Real-Sampietro L; Saló F; Lloret A; Bardagí M
    J Feline Med Surg; 2020 Oct; 22(10):993-1007. PubMed ID: 32053024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feline leishmaniosis: hematological and biochemical analysis.
    Silva DTD; Alves ML; Spada JCP; Leonel JAF; Vioti G; Benassi JC; Carregaro VML; Alves-Martin MF; Starke-Buzetti WA; Oliveira TMFS
    Rev Bras Parasitol Vet; 2023; 32(2):e003823. PubMed ID: 37377321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serological and molecular study of Leishmania infantum infection in cats from the Island of Ibiza (Spain).
    Sherry K; Miró G; Trotta M; Miranda C; Montoya A; Espinosa C; Ribas F; Furlanello T; Solano-Gallego L
    Vector Borne Zoonotic Dis; 2011 Mar; 11(3):239-45. PubMed ID: 20804432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline and canine leishmaniosis and other vector-borne diseases in the Aeolian Islands: Pathogen and vector circulation in a confined environment.
    Otranto D; Napoli E; Latrofa MS; Annoscia G; Tarallo VD; Greco G; Lorusso E; Gulotta L; Falsone L; Basano FS; Pennisi MG; Deuster K; Capelli G; Dantas-Torres F; Brianti E
    Vet Parasitol; 2017 Mar; 236():144-151. PubMed ID: 28288759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Feline leishmaniasis: what's the epidemiological role of the cat?].
    Mancianti F
    Parassitologia; 2004 Jun; 46(1-2):203-6. PubMed ID: 15305717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional study of Leishmania infantum infection in stray cats in the city of Zaragoza (Spain) using serology and PCR.
    Alcover MM; Basurco A; Fernandez A; Riera C; Fisa R; Gonzalez A; Verde M; Garrido AM; Ruíz H; Yzuel A; Villanueva-Saz S
    Parasit Vectors; 2021 Mar; 14(1):178. PubMed ID: 33766113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of feline leishmaniosis with an imidacloprid 10%/flumethrin 4.5% polymer matrix collar.
    Brianti E; Falsone L; Napoli E; Gaglio G; Giannetto S; Pennisi MG; Priolo V; Latrofa MS; Tarallo VD; Solari Basano F; Nazzari R; Deuster K; Pollmeier M; Gulotta L; Colella V; Dantas-Torres F; Capelli G; Otranto D
    Parasit Vectors; 2017 Jul; 10(1):334. PubMed ID: 28705248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania infantum-specific IFN-γ production in stimulated blood from cats living in areas where canine leishmaniosis is endemic.
    Priolo V; Martínez-Orellana P; Pennisi MG; Masucci M; Prandi D; Ippolito D; Bruno F; Castelli G; Solano-Gallego L
    Parasit Vectors; 2019 Mar; 12(1):133. PubMed ID: 30909952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What do we know about feline leishmaniosis?
    Soares CS; Duarte SC; Sousa SR
    J Feline Med Surg; 2016 Jun; 18(6):435-42. PubMed ID: 26116620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A global perspective on non-autochthonous canine and feline Leishmania infection and leishmaniosis in the 21st century.
    Rocha R; Pereira A; Maia C
    Acta Trop; 2023 Jan; 237():106710. PubMed ID: 36198329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
    de Jong MK; Rappoldt A; Broere F; Piek CJ
    Parasit Vectors; 2023 May; 16(1):163. PubMed ID: 37189181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.